Affordable Access

Combined IL-2 and IL-12 gene therapy for murine head and neck squamous cell carcinoma.

Authors
  • Liu, Shixi
  • Yang, Huan
  • Liang, Chuanyu
Type
Published Article
Journal
Zhonghua zhong liu za zhi [Chinese journal of oncology]
Publication Date
Jul 01, 2002
Volume
24
Issue
4
Pages
323–326
Identifiers
PMID: 12408755
Source
Medline
License
Unknown

Abstract

Both IL-2 and IL-12 gene therapy is able to inhibit the growth of HNSCC and induce the host antitumor immune response efficiently in the murine model. Combination of the two in gene therapy may be additive or synergistic in antitumor effect.

Report this publication

Statistics

Seen <100 times